CPAY:NYE-Corpay Inc (USD)

COMMON STOCK | Others |

Last Closing

USD 303.8

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.25M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

N/A

USD 65.72B
JEPI JPMorgan Equity Premium Income..

N/A

USD 32.43B
DTB DTB

N/A

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

N/A

USD 26.00B
GBTC Grayscale Bitcoin Trust (BTC)

N/A

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 22.73B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 19.79B
AVUV Avantis® U.S. Small Cap Value..

N/A

USD 10.49B
DFUV Dimensional US Marketwide Valu..

N/A

USD 10.15B
DFAT Dimensional U.S. Targeted Valu..

N/A

USD 9.40B

ETFs Containing CPAY

C073:F 9.28 % 0.00 %

N/A

N/A
C073:XETRA 9.28 % 0.00 %

N/A

N/A
CECD:LSE 9.05 % 0.00 %

N/A

N/A
EWQ iShares MSCI France ETF 5.68 % 0.47 %

N/A

USD 0.64B
FLFR 5.65 % 0.09 %

N/A

N/A
EQLT:LSE 4.90 % 0.00 %

N/A

N/A
CMU:PA Amundi MSCI EMU ESG Leade.. 4.74 % 0.00 %

N/A

USD 1.33B
IPAY:AU BetaShares Future of Paym.. 4.69 % 0.00 %

N/A

N/A
36B3:F iShares MSCI Europe SRI U.. 4.41 % 0.00 %

N/A

N/A
LESE:F 4.16 % 0.00 %

N/A

N/A
LESE:XETRA 4.16 % 0.00 %

N/A

N/A
EESG:LSE 3.60 % 0.00 %

N/A

N/A
1385:TSE 3.25 % 0.00 %

N/A

N/A
IUSR:F 3.23 % 0.00 %

N/A

N/A
IUSR:XETRA 3.23 % 0.00 %

N/A

N/A
E950:F 3.09 % 0.00 %

N/A

N/A
E950:XETRA 3.09 % 0.00 %

N/A

N/A
3165:HK ChinaAMC MSCI Europe Qual.. 3.04 % 0.00 %

N/A

N/A
XD5F:LSE 3.02 % 0.00 %

N/A

N/A
ZEQ:CA BMO MSCI Europe High Qual.. 2.93 % 0.45 %

N/A

CAD 0.77B
C050:F 2.91 % 0.00 %

N/A

N/A
C054:F 2.91 % 0.00 %

N/A

N/A
C050:XETRA 2.91 % 0.00 %

N/A

N/A
C054:XETRA 2.91 % 0.00 %

N/A

N/A
EHE-B:CA WisdomTree Europe Hedged .. 2.90 % 0.00 %

N/A

CAD 0.01B
KXI iShares Global Consumer S.. 2.87 % 0.46 %

N/A

USD 0.84B
EUDG WisdomTree Europe Quality.. 2.52 % 0.58 %

N/A

USD 0.07B
MSED:PA 2.31 % 0.00 %

N/A

N/A
MSED:F 2.31 % 0.00 %

N/A

N/A
MSED:XETRA 2.31 % 0.00 %

N/A

N/A
MTDB:XETRA 2.31 % 0.00 %

N/A

N/A
IQDY FlexShares International .. 2.21 % 0.47 %

N/A

USD 0.07B
MFDD:PA 2.14 % 0.00 %

N/A

N/A
1387:TSE 2.13 % 0.00 %

N/A

N/A
IQDF FlexShares International .. 2.12 % 0.47 %

N/A

USD 0.55B
FLEH 2.00 % 0.09 %

N/A

N/A
XD5E:XETRA Xtrackers MSCI EMU UCITS .. 1.98 % 0.00 %

N/A

USD 0.96B
UC89:LSE 1.91 % 0.00 %

N/A

N/A
FRCA:XETRA 1.91 % 0.00 %

N/A

N/A
EMUE:LSE 1.90 % 0.00 %

N/A

N/A
FLEU Barclays ETN+ FI Enhanced.. 1.88 % 0.00 %

N/A

USD 2.78M
DBEZ Xtrackers MSCI Eurozone H.. 1.78 % 0.47 %

N/A

USD 0.04B
IQDE FlexShares International .. 1.62 % 0.47 %

N/A

USD 0.02B
EASG Xtrackers MSCI EAFE ESG L.. 1.36 % 0.00 %

N/A

USD 0.05B
XDLR:CA 1.36 % 0.00 %

N/A

N/A
EFG 1.33 % 0.40 %

N/A

N/A
QINT American Century Quality .. 1.27 % 0.00 %

N/A

USD 0.23B
SMLU:F 0.95 % 0.00 %

N/A

N/A
FLSP Franklin Liberty Systemat.. 0.80 % 0.00 %

N/A

USD 0.18B

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike